Cleveland Clinic’s 27th Annual Structural Valve Imaging Summit provides a comprehensive overview of valve disease, structural interventions and cardiac imaging. An expert faculty discusses state-of-the-art technology and advanced imaging topics such as strain and 3-D, pericardial diseases, amyloid, HCM and artificial intelligence. In addition to didactic lectures, this summit features complex case presentations, workshop demonstrations and spirited debates over several controversial topics.
* Date of Original Release: April 30, 2025
LEARNING OBJECTIVE
At the conclusion of this activity, the participant will be able to:
Apply multimodality imaging, including echo, CT, and MRI, to assess the severity and hemodynamic impact of valvular heart disease and identify recent advancements in CT and MRI technology and their implications for mitral valve assessment in 2025.
Evaluate the most recent innovations in surgical approaches, including artificial intelligence, for diseases of the mitral valve, aortic valve, tricuspid valve and left atrial appendage.
Apply updated imaging guideline criteria to inform decision-making for structural valve interventions, medical therapies and surgical valve repair or replacement.
Discuss recent advancements in diastology and the role of left atrial (LA) strain in diagnosis.
Describe advances in cardio-oncology, recurrent pericarditis, constrictive pericarditis, cardiac amyloidosis and hypertrophic cardiomyopathy.
Assess emerging approaches to sarcoid heart disease, atrial septal defects (ASDs), mechanical support for heart failure and ultrasound contrast agents in routine practice.